Table 3.
Circulating protein levels of the insulin/IGF system in ovarian cancer.
| Insulin/IGF components | No. of patients | Modulation | Reference |
|---|---|---|---|
| IGFBP-2 | 20 EOC | ↑ | [49] |
| IGF-I | 58 EOC | ↓ | [53] |
| IGF-I | 24 EOC | ↓ | [52] |
| IGF-I | 59 EOC | ↓ | [54] |
| IGF-I | 9 EOC | ↓ | [55] |
| IGF-I | 132 EOC (<55 yrs.) | ↑ | [56] |
| IGF-I | 214 EOC (<55 yrs.) | ↑ | [57] |
| IGF-I, IGFBP-2, IGFBP-3 | 222 EOC | ↔ | [58] |
EOC: epithelial ovarian cancer.